نتائج البحث

Anti-Xa Activity Test Is Needed but Is Not Enough for Monitoring Fondaparinux Therapy Among Critically Ill Patients.

• Authors : Ling L; From the Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China (Ling, C. Liu, Huang, Liao, Jia, Fu, Zhou).; Liu C

Subjects: Fondaparinux*/Fondaparinux*/Fondaparinux*/therapeutic use ; Critical Illness* ; Factor Xa Inhibitors*/Factor Xa Inhibitors*/Factor Xa Inhibitors*/therapeutic use

• Source: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2025 Jan 01; Vol. 149 (1), pp. e11-e18.Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

Treatment with Aspirin Alone Versus Aspirin in Combination with Fondaparinux Before Early Coronary Assessment in Patients with Non-ST-Elevation Myocardial Infarction (FOXY)

• Authors : Danske Regioner; Aalborg University Hospital; Odense University Hospital

• Source: Aspirin Versus Aspirin and Fondaparinux Prior to Early Invasive Strategy in Patients with NSTEMIKvalitetsudviklingsprogram RK. Dansk Hjerteregister - Årsrapport

تفاصيل العنوان

Clinical outcomes of patients receiving long-term fondaparinux for thrombotic antiphospholipid syndrome.

• Authors : Bor B; Faculty of Medicine, University of Aarhus, Aarhus, Denmark.; Centre for Haemostasis and Thrombosis, Guy's & St Thomas NHS Foundation Trust, London, UK.

Subjects: Fondaparinux*/Fondaparinux*/Fondaparinux*/therapeutic use ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/drug therapy ; Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/Antiphospholipid Syndrome*/complications

• Source: Lupus [Lupus] 2024 Nov; Vol. 33 (13), pp. 1446-1454. Date of Electronic Publication: 2024 Sep 16.Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Comparison of efficacy of nadroparin and fondaparinux sodium for prevention of deep vein thromboembolism in lower extremities after total hip arthroplasty and total knee arthroplasty: a retrospective study of 592 patients

• Authors : Xiang Gao; Xiaowei Jin; Rui Huang

Subjects: Deep vein Thromboembolism; Nadroparin; Fondaparinux Sodium

• Source: BMC Surgery, Vol 24, Iss 1, Pp 1-8 (2024)

تفاصيل العنوان

Fondaparinux versus Enoxaparina no Tratamento de Pacientes Obesos com Síndrome Coronariana Aguda

• Authors : Beatriz Rocha Darzé; Carolina Costa da Silva Souza; Queila Borges de Oliveira

Subjects: Anticoagulantes; Enoxaparina; Fondaparinux

• Source: Arquivos Brasileiros de Cardiologia, Vol 121, Iss 8 (2024)

تفاصيل العنوان

Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels (UniXa)

• Source: Multicentric Prospective Validation of a Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and Fondaparinux Levels

تفاصيل العنوان

A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary Bypass Surgery Receiving Routine Mechanical Prophylaxis

• Authors : American College of Phlebology

• Source: A Study of the Efficacy of Preventive Dosing of Fondaparinux Sodium Versus Placebo for the Prevention of Venous Thromboembolism (VTE) in Patients Undergoing Coronary

تفاصيل العنوان

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

• Authors : Bayer

• Source: Superficial Vein Thrombosis (SVT) Treated for Forty-five Days With Rivaroxaban Versus FondaparinuxKearon C, Carrier M, Gu CS, Schulman S, Bates SM, Kahn SR,

تفاصيل العنوان

Efficacy and Safety Study of Low-Molecular-Weight Heparin and Fondaparinux Sodium After Hip Arthroplasty: A Retrospective Cohort Study

• Authors : Haibier A; Yusufu A; Lin H

Subjects: hip osteoarthritis; total hip arthroplasty; low-molecular-weight heparin

• Source: Orthopedic Research and Reviews, Vol Volume 15, Pp 253-261 (2023)

تفاصيل العنوان

Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients

• Authors : GlaxoSmithKline

• Source: Safety of Fondaparinux as Routine VTE Prophylaxis in Medical ICU Patients: An Investigator Initiated Protocol

تفاصيل العنوان